Varaico: Literature-Extracted Genetic Variants

Gene:SCN5A
Variant:p.L618F
Back to variants list

SCN5A

NM_000335.5:p.L618F

Associated Papers

Precision therapy in congenital long QT syndrome.

Neves R et al.

Trends in Cardiovascular Medicine, 2024

Multi-site validation of a functional assay to adjudicate SCN5A Brugada Syndrome-associated variants.

Ma JG et al.

Medrxiv : the Preprint Server for Health Sciences, 2023

The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findings.

McGurk KA et al.

American Journal of Human Genetics, 2023

37652022 (PubMed )
Supplement: mmc3.xlsx › Table_S11

Whole-exome sequencing analyses in a Saudi Ischemic Stroke Cohort reveal association signals, and shows polygenic risk scores are related to Modified Rankin Scale Risk.

Alkhamis FA et al.

Functional & Integrative Genomics, 2023

36973604 (PubMed )
Supplement: 10142_2023_1039_MOESM1_ESM.xlsx › all_variants

Protein domains provide a new layer of information for classifying human variations in rare diseases.

Corcuff M et al.

Frontiers in Bioinformatics, 2023

36896423 (PubMed )
Supplement: Table1.XLSX › Supplementary_Table_1

Clinical significance of genetic variation in hypertrophic cardiomyopathy: comparison of computational tools to prioritize missense variants.

Barbosa P et al.

Frontiers in Cardiovascular Medicine, 2022

36061567 (PubMed )
Supplement: Table_1.XLSX › Table_S2

The role of sodium channels in sudden unexpected death in pediatrics.

Rochtus AM et al.

Molecular Genetics & Genomic Medicine, 2020

An African loss-of-function CACNA1C variant p.T1787M associated with a risk of ventricular fibrillation.

Blancard M et al.

Scientific Reports, 2018

Predicting changes to INa from missense mutations in human SCN5A.

Clerx M et al.

Scientific Reports, 2018

30143662 (PubMed )
Supplement: 41598_2018_30577_MOESM1_ESM.pdf

Sudden infant death syndrome due to long QT syndrome: a brief review of the genetic substrate and prevalence.

Ioakeimidis NS et al.

Journal of Biological Research (thessalonike, Greece), 2017

Clinical laboratories collaborate to resolve differences in variant interpretations submitted to ClinVar.

Harrison SM et al.

Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2017

28301460 (PubMed )
Supplement: NIHMS853375-supplement-Supplemental_Table_4__Consensus_classifications_for_all_211_resolved_variants.xlsx › Supplemental_Table_4

Congenital long QT syndrome: A difficult journey for one young survivor.

Saarel EV et al.

Heartrhythm Case Reports, 2015

Assessment of the predictive accuracy of five in silico prediction tools, alone or in combination, and two metaservers to classify long QT syndrome gene mutations.

Leong IU et al.

Bmc Medical Genetics, 2015

25967940 (PubMed )
Supplement: 12881_2015_176_MOESM1_ESM.xlsx › SCN5A_BrS

Examining rare and low-frequency genetic variants previously associated with lone or familial forms of atrial fibrillation in an electronic medical record system: a cautionary note.

Weeke P et al.

Circulation. Cardiovascular Genetics, 2015

Identification of Medically Actionable Secondary Findings in the 1000 Genomes.

Olfson E et al.

Plos One, 2015

26332594 (PubMed )
Supplement: pone.0135193.s002.xls › Sheet1

The genetics of pro-arrhythmic adverse drug reactions.

Petropoulou E et al.

British Journal of Clinical Pharmacology, 2014

Cardiac channelopathy testing in 274 ethnically diverse sudden unexplained deaths.

Wang D et al.

Forensic Science International, 2014

Atrial fibrillation: the role of common and rare genetic variants.

Olesen MS et al.

European Journal of Human Genetics : Ejhg, 2014

Integrated analysis of germline and somatic variants in ovarian cancer.

Kanchi KL et al.

Nature Communications, 2014

24448499 (PubMed )
Supplement: NIHMS551112-supplement-7.xlsx › S_Data_6

CaMKII-dependent regulation of cardiac Na(+) homeostasis.

Grandi E et al.

Frontiers in Pharmacology, 2014

High prevalence of genetic variants previously associated with LQT syndrome in new exome data.

Refsgaard L et al.

European Journal of Human Genetics : Ejhg, 2012

22378279 (PubMed )
Supplement: ejhg201223x1.doc

Pharmacogenomics of cardiovascular drugs and adverse effects in pediatrics.

Visscher H et al.

Journal of Cardiovascular Pharmacology, 2011

Facilitatory and inhibitory effects of SCN5A mutations on atrial fibrillation in Brugada syndrome.

Amin AS et al.

Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, 2011

A new approach to long QT syndrome mutation detection by Sequenom MassARRAY system.

Allegue C et al.

Electrophoresis, 2010

An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.

Kapplinger JD et al.

Heart Rhythm, 2010

Exercise-induced ECG changes in Brugada syndrome.

Amin AS et al.

Circulation. Arrhythmia and Electrophysiology, 2009

A mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation.

Benito B et al.

Heart Rhythm, 2008

Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation.

Darbar D et al.

Circulation, 2008

Pharmacogenetics of drug-induced arrhythmias.

Abbott GW et al.

Expert Review of Clinical Pharmacology, 2008

Role of sodium channels in propagation in heart muscle: how subtle genetic alterations result in major arrhythmic disorders.

Terrenoire C et al.

Journal of Cardiovascular Electrophysiology, 2007

The relationship between the pharmacology of antiepileptic drugs and human gene variation: an overview.

Ferraro TN et al.

Epilepsy & Behavior : E&b, 2005

Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.

Tester DJ et al.

Heart Rhythm, 2005

Risk factors for drug-induced long-QT syndrome.

Paulussen AD et al.

Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2005

Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients.

Paulussen AD et al.

Journal of Molecular Medicine (berlin, Germany), 2004

Contribution of sodium channel mutations to bradycardia and sinus node dysfunction in LQT3 families.

Veldkamp MW et al.

Circulation Research, 2003

12676817 (PubMed )
Supplement: 5131-r2_online.pdf

A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating.

Wehrens XH et al.

Human Mutation, 2003

Genetic control of sodium channel function.

Tan HL et al.

Cardiovascular Research, 2003

SCN5A channelopathies--an update on mutations and mechanisms.

Zimmer T et al.

Progress in Biophysics and Molecular Biology, 0

Susceptibility genes & modifiers for cardiac arrhythmias.

Schulze-Bahr E

Progress in Biophysics and Molecular Biology, 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."